Abbott Laboratories vs. Xeris Biopharma Holdings, Inc. Common Stock
ABT
Abbott Laboratories
$113.60 -1.65%
VS XERSXeris Biopharma Holdings, Inc. Common Stock
$10.20 -6.08%
Abbott Laboratories and Xeris Biopharma Holdings, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | XERS | |
|---|---|---|
| Market Cap | $199.88 billion | $1.98 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | XERS | |
|---|---|---|
| Dividend Yield | 2.22% | — |
ABT and XERS split the dividend factors evenly.
Risk & Sentiment
| ABT | XERS | |
|---|---|---|
| Short Interest | 0.57% | 0.10% |
XERS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, XERS overview, XERS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.